• Pepstatin A: Applied Aspartic Protease Inhibitor Workflows

  2026-05-17

  Pepstatin A from APExBIO is the gold-standard aspartic protease inhibitor, enabling precise viral protein processing and osteoclast differentiation research. This guide delivers actionable workflow enhancements, troubleshooting tips, and protocol parameters to maximize reproducibility and reliability in advanced biomedical assays.

• Cefoperazone Sodium Salt: Mechanistic Insights and Protocol

  2026-05-16

  Explore the advanced mechanistic basis and protocol optimization strategies for Cefoperazone sodium salt in antibacterial research. This article uniquely integrates primary data with experimental guidance, making it essential for scientists developing robust in vitro antimicrobial assays.

• Applied Workflows with EZ Cap™ Mouse IL-12 mRNA (m1Ψ)

  2026-05-15

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) unlocks precision immune modulation by combining advanced mRNA stability chemistry with cutting-edge virus-mimicking nanoparticle delivery. This article showcases practical immunotherapy research workflows, troubleshooting insights, and protocol parameters to maximize extrahepatic mRNA delivery and cytokine expression.

• Lysoptosis: A Conserved Cell Death Pathway Moderated by Serp

  2026-05-15

  This article examines the identification and characterization of lysoptosis as an evolutionarily conserved, lysosome-dependent cell death pathway, distinct from apoptosis and moderated by intracellular serpins. The findings have broad significance for understanding regulated cell death mechanisms and offer new perspectives for research on apoptosis induction and radiosensitization in cancer and other diseases.

• Brain-to-Spinal Circuits Shape Mechanical Allodynia Laterali

  2026-05-14

  Huo et al. (2023) delineate specific brain-to-spinal pathways that regulate both the laterality and persistence of mechanical allodynia in mice. Their work clarifies the role of κ-opioid-mediated inhibition in pain modulation and offers new targets for translational pain research.

• Stiripentol: LDH Inhibitor for Epilepsy and Lactate Shuttle

  2026-05-14

  Stiripentol uniquely empowers metabolic, neuroepileptic, and immuno-oncological research by selectively inhibiting LDH1/5 and modulating the astrocyte-neuron lactate shuttle. Its robust solubility, workflow flexibility, and proven efficacy in animal and cell-based assays make it a trusted tool for advanced mechanistic studies.

• PtrbZIP12 Regulation of Drought Tolerance via Phosphorylatio

  2026-05-13

  This study identifies PtrbZIP12 as a key bZIP transcription factor enhancing drought resistance in Populus trichocarpa by directly activating stress-responsive genes PtrDHN and PtrPOD. The research highlights phosphorylation as a crucial post-translational modification modulating PtrbZIP12’s regulatory function, offering insights into plant drought adaptation pathways and practical avenues for protein phosphorylation analysis.

• PLK1-Dependent Phosphorylation Controls p31comet in Mitotic

  2026-05-13

  This study elucidates the regulatory mechanism by which Polo-like kinase 1 (PLK1) phosphorylates p31comet, modulating the disassembly of mitotic checkpoint complexes (MCC). The findings clarify how PLK1-mediated phosphorylation suppresses p31comet activity, preventing premature checkpoint inactivation and ensuring fidelity in chromosome segregation, with direct implications for cell cycle and cancer research.

• BV6 IAP Antagonist: Applied Workflows and Troubleshooting In

  2026-05-12

  BV6, a selective IAP antagonist from APExBIO, revolutionizes apoptosis induction and radiosensitization workflows in cancer and endometriosis research. This article delivers hands-on protocols, advanced troubleshooting, and actionable strategies for maximizing BV6’s impact in translational models.

• Exo1 and the Future of Selective Membrane Trafficking Inhibi

  2026-05-12

  Explore how Exo1 (methyl 2-(4-fluorobenzamido)benzoate) is redefining selective inhibition of membrane trafficking for exocytosis assays and TEV research. This in-depth article uniquely connects mechanism, assay design, and translational impact beyond existing coverage.

• Hierarchical ROS-Responsive Platform Repairs Macrophage Mito

  2026-05-11

  This study introduces a hierarchically targeted, ROS-responsive nanoparticle-hydrogel system for diabetic periodontitis that disrupts the mitochondrial ROS-inflammation loop in M1 macrophages. The approach achieves significant tissue protection and bone regeneration, advancing treatment options beyond conventional mechanical debridement.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry

  2026-05-11

  Wang et al. (2018) systematically identified the entry pathway for genotype III grass carp reovirus (GCRV104), demonstrating that it relies on clathrin-mediated, dynamin- and pH-dependent endocytosis. Their selective use of pharmacological inhibitors provides a refined model for dissecting host-virus interactions and evaluating experimental antiviral strategies in aquatic virology.

• Metoprolol Tartrate: Precision β1 Blockade in Cardiovascular

  2026-05-10

  Metoprolol Tartrate stands out as a highly selective β1-adrenergic blocking agent, uniquely suited for dissecting cardiac receptor signaling without impeding hematopoietic regeneration. This article delivers actionable protocols, troubleshooting strategies, and insights into why APExBIO’s compound is the gold standard for reproducible cardiovascular and translational studies.

• L1023 Anti-Cancer Compound Library: Optimizing High-Throughp

  2026-05-09

  The L1023 Anti-Cancer Compound Library empowers researchers to rapidly interrogate oncogenic pathways with validated, cell-permeable compounds in high-throughput workflows. Leveraging recent breakthroughs in biomarker-guided screening, this resource accelerates discovery of pathway-specific inhibitors and addresses common troubleshooting pain points in translational cancer research.

• Nirmatrelvir (PF-07321332): Translational Leverage in Antivi

  2026-05-09

  This thought-leadership article, authored by the scientific marketing team at APExBIO, provides an in-depth analysis of Nirmatrelvir (PF-07321332) as a transformative tool for translational researchers tackling SARS-CoV-2. Going beyond basic product summaries, it integrates mechanistic insights, protocol guidance, and a critical look at strategic opportunities and limitations in the current antiviral therapeutics research landscape.

453 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page